Real-world treatment patterns and survival in men with metastatic castration-resistant prostate cancer (mCRPC) who previously progressed from metastatic hormone-sensitive prostate cancer (mHSPC) between 2020 to 2023 in the United States.

被引：0
|
作者：
Raval, Amit D.
Chen, Guifang
Korn, Matthew J.
Bernthaler, Andreas
Constantinovici, Niculae
Freedland, Stephen J.
机构：
[1] Bayer Healthcare Pharmaceut Inc, Whippany, NJ USA
[2] Bayer AG, Berlin, Germany
[3] Bayer Consumer Care AG, Basel, Switzerland
[4] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Dept Urol, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 5_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.5_suppl.99
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Outcomes of patients (pts) with de novo metastatic hormone-sensitive prostate cancer (mHSPC) who progressed to metastatic castration-resistant prostate cancer (mCRPC): A post-hoc analysis of the TRUMPET registry.
    Shevrin, Daniel H.
    Symanowski, James Thomas
    Shore, Neal D.
    Lin, Daniel W.
    Russell, David
    Kral, Pavol
    Song, Yi
    El-Chaar, Nader N.
    Karsh, Lawrence Ivan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Real-world baseline treatment patterns and overall survival (rwOS) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with olaparib in the United States.
    Kariburyo-Yay, Furaha
    George, Daniel J.
    Aggarwal, Himani
    Tepsick, Jon G.
    Yu, Rebekah
    Li, Weiyan
    Orji, Chinelo
    Lal, Lincy S.
    Ghate, Sameer R.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Real-world treatment patterns and overall survival among men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) in the US Medicare population
    Freedland, Stephen J.
    Davis, Matthew
    Epstein, Andrew J.
    Arondekar, Bhakti
    Ivanova, Jasmina I.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024, 27 (02) : 327 - 333
  • [4] Real-world treatment patterns and overall survival among men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) in the US Medicare population
    Stephen J. Freedland
    Matthew Davis
    Andrew J. Epstein
    Bhakti Arondekar
    Jasmina I. Ivanova
    Prostate Cancer and Prostatic Diseases, 2024, 27 : 327 - 333
  • [5] Determination of direct treatment costs of patients with metastatic and nonmetastatic castration-resistant (mCRPC, nmCRPC) and metastatic hormone-sensitive (mHSPC) prostate cancer in Colombia.
    Nino, Rafael
    Restrepo-Miranda, Diego
    Amezquita, Miguel Alberto
    Lancheros, Jeisson
    Corredor, Lina Maria
    Medina, Yudy
    Aguirre, Andres
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18838 - E18838
  • [6] Real-world treatment patterns among men with metastatic castration-resistant prostate cancer (mCRPC) in the US Medicare population.
    Freedland, Stephen J.
    Davis, Matthew
    Epstein, Andrew J.
    Arondekar, Bhakti
    Ivanova, Jasmina I.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 406 - 406
  • [7] Real-world evidence of treatment patterns and pharmacy costs among patients with metastatic castration-resistant prostate cancer (mCRPC) in a managed care population in the United States.
    Moses, Kelvin A.
    Wallace, Katrine
    Landsteiner, Adrienne
    Bunner, Scott
    Engel-Nitz, Nicole
    Lal, Lincy S.
    Golsorkhi, Anthony A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Real-world treatment (Tx) patterns of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) in the US
    Shore, N.
    Laliberte, F.
    Ionescu-Ittu, R.
    Gayle, A.
    Amin, S.
    Yang, L.
    Payne, S.
    Mahendran, M.
    Lejeune, D.
    Yu, L.
    Burgents, J.
    Duh, M. S.
    Ghate, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S534 - S535
  • [9] Real-world treatment patterns among patients with metastatic castration-resistant prostate cancer (mCRPC) in the US.
    Malangone-Monaco, Elisabetta
    Li, Weiyan
    Noxon, Virginia
    Jiang, Shan
    Amin, Suvina
    Ghate, Sameer
    Swami, Umang
    Agarwali, Neeraj
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [10] Treatment patterns and healthcare resource utilization in patients with metastatic hormone-sensitive prostate cancer and nonmetastatic castration-resistant prostate cancer in China: a real-world observational study
    Wang, Yong
    Liu, Chunxiao
    Liu, Chuan
    Lu, Yongji
    Ban, Lu
    Niu, Yuanjie
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 361 - 369
12345